Association between musculoskeletal function deterioration and locomotive syndrome in the general elderly population: a Japanese cohort survey randomly sampled from a basic resident registry.
Aged
Aged, 80 and over
Cohort Studies
Cross-Sectional Studies
Disability Evaluation
Female
Geriatric Assessment
/ methods
Humans
Japan
/ epidemiology
Locomotion
/ physiology
Male
Middle Aged
Mobility Limitation
Physical Examination
Prevalence
Registries
Sarcopenia
/ epidemiology
Sex Factors
Surveys and Questionnaires
Syndrome
Cross-sectional survey
Epidemiological study
Locomotion, physical examination
Prevalence
Sarcopenia
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
03 Jul 2020
03 Jul 2020
Historique:
received:
17
03
2020
accepted:
29
06
2020
entrez:
5
7
2020
pubmed:
6
7
2020
medline:
10
4
2021
Statut:
epublish
Résumé
Locomotive syndrome (LoS) is defined as the loss of mobility due to age-related impairment of motor organs. The purpose of this study was to evaluate the prevalence and severity of LoS, muscular strength and balancing ability, and prevalence of sarcopenia in relation to the presence of LoS according to sex and age groups ranging between 50 and 89 years. Male and female participants between the ages of 50-89 were randomly selected in the resident registry of a cooperating town. Calls for participation continued until approximately 50 consenting participants were successfully recruited for each age group and sex. A total of 413 participants (203 male and 210 female) were enrolled for undergoing a LoS risk test and measuring their physical function. Physical function was compared to participants with or without LoS. A total of 312 patients (75.5%) were diagnosed as LoS, of which 144 (46.2%) were male and 168 (53.8%) were female. The severity of LoS for the 312 patients were 210 (67.3%) for stage 1 and 102 (32.7%) for stage 2. The prevalence of LoS in males were 37, 59, 91, and 100% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of LoS in females were 71, 62, 89, and 98% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of sarcopenia was significantly higher as the age strata in males grew higher. Knee extension strength was significantly lower for participants in their 50s and females in addition to females in their 60s with LoS. The 31 patients diagnosed as sarcopenia included 29 (93.5%) with LoS, 11 (35.4%) classified as LoS stage 1, and 18 (58.1%) classified as stage 2. The prevalence of LoS was high in participants over 70 years of age. In males, the prevalence of sarcopenia was higher as the age strata grew higher. Patients with LoS exhibited lower knee extension strength. We believe that some measures to prevent or improve LoS may require exercise to increase the muscle strength of the lower limbs.
Sections du résumé
BACKGROUND
BACKGROUND
Locomotive syndrome (LoS) is defined as the loss of mobility due to age-related impairment of motor organs. The purpose of this study was to evaluate the prevalence and severity of LoS, muscular strength and balancing ability, and prevalence of sarcopenia in relation to the presence of LoS according to sex and age groups ranging between 50 and 89 years.
METHODS
METHODS
Male and female participants between the ages of 50-89 were randomly selected in the resident registry of a cooperating town. Calls for participation continued until approximately 50 consenting participants were successfully recruited for each age group and sex. A total of 413 participants (203 male and 210 female) were enrolled for undergoing a LoS risk test and measuring their physical function. Physical function was compared to participants with or without LoS.
RESULTS
RESULTS
A total of 312 patients (75.5%) were diagnosed as LoS, of which 144 (46.2%) were male and 168 (53.8%) were female. The severity of LoS for the 312 patients were 210 (67.3%) for stage 1 and 102 (32.7%) for stage 2. The prevalence of LoS in males were 37, 59, 91, and 100% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of LoS in females were 71, 62, 89, and 98% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of sarcopenia was significantly higher as the age strata in males grew higher. Knee extension strength was significantly lower for participants in their 50s and females in addition to females in their 60s with LoS. The 31 patients diagnosed as sarcopenia included 29 (93.5%) with LoS, 11 (35.4%) classified as LoS stage 1, and 18 (58.1%) classified as stage 2.
CONCLUSIONS
CONCLUSIONS
The prevalence of LoS was high in participants over 70 years of age. In males, the prevalence of sarcopenia was higher as the age strata grew higher. Patients with LoS exhibited lower knee extension strength. We believe that some measures to prevent or improve LoS may require exercise to increase the muscle strength of the lower limbs.
Identifiants
pubmed: 32620119
doi: 10.1186/s12891-020-03469-x
pii: 10.1186/s12891-020-03469-x
pmc: PMC7334862
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
431Subventions
Organisme : The Japan Orthopaedics and Traumatology Research Foundation, Inc.
ID : 339
Références
Clin Interv Aging. 2018 Apr 30;13:819-827
pubmed: 29750024
Osteoporos Int. 2017 Jan;28(1):189-199
pubmed: 27885410
J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):48-55
pubmed: 21393423
J Orthop Sci. 2019 Sep;24(5):912-917
pubmed: 30773352
J Rehabil Med. 2010 Jun;42(6):588-92
pubmed: 20549165
J Bone Miner Metab. 2019 Nov;37(6):1058-1066
pubmed: 31222550
Physiother Theory Pract. 2013 Nov;29(8):639-47
pubmed: 23724831
Osteoporos Sarcopenia. 2018 Sep;4(3):86-94
pubmed: 30775549
Clin Rev Bone Miner Metab. 2016;14:56-67
pubmed: 27375370
J Orthop Sci. 2008 Jan;13(1):1-2
pubmed: 18274847
Prev Chronic Dis. 2014 Aug 21;11:E141
pubmed: 25144676
Nihon Koshu Eisei Zasshi. 2016;63(9):549-559
pubmed: 27818468
Mod Rheumatol. 2017 Jan;27(1):1-7
pubmed: 27538793
J Orthop Sci. 2012 Mar;17(2):163-72
pubmed: 22222445
J Bone Miner Res. 2018 Jul;33(7):1209-1218
pubmed: 29502340
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
Clin Interv Aging. 2019 Aug 05;14:1399-1405
pubmed: 31496667
BMC Musculoskelet Disord. 2017 Nov 15;18(1):452
pubmed: 29141602
J Phys Ther Sci. 2013 Nov;25(11):1451-4
pubmed: 24396208
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Mod Rheumatol. 2017 Nov;27(6):1051-1056
pubmed: 28933238
J Orthop Sci. 2015 Sep;20(5):896-905
pubmed: 26104219